SCHEMBL16623428

SCHEMBL16623428

COC(=O)C[C@@H](Br)C(=O)C(=O)OC

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TET2 Q6N021 1/20 0.39
TSHR P16473 4/20 0.39
HSD17B10 Q99714 1/20 0.36
MGAM O43451 1/20 0.36
GAA P10253 1/20 0.36
SI P14410 1/20 0.36
MGAM2 Q2M2H8 1/20 0.36
ZDHHC7 Q9NXF8 1/20 0.33
KCNA5 P22460 1/20 0.31
ALDH1A1 P00352 1/20 0.31
TP53 P04637 1/20 0.31
TGFBR1 P36897 1/20 0.31
MEN1 O00255 1/20 0.30
KMT2A Q03164 1/20 0.30
EGLN1 Q9GZT9 1/20 0.30
MAPT P10636 1/20 0.30
RAB9A P51151 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1444812 1.00 TET2 (0.39) TET2TSHRHSD17B10MGAMGAA
SCHEMBL12451759 0.83 MGAM (0.41) TET2TSHRHSD17B10MGAMGAA
SCHEMBL17398486 0.83 EGLN1 (0.39) TET2TSHRZDHHC7ALDH1A1TGFBR1
SCHEMBL27848612 0.83 TSHR (0.39) TET2TSHRHSD17B10MGAMGAA
SCHEMBL15110273 0.77 ALDH1A1 (0.41) TET2TSHRZDHHC7ALDH1A1TGFBR1
SCHEMBL8899182 0.77 TSHR (0.44) TET2TSHRHSD17B10MGAMGAA
SCHEMBL11274143 0.77 ZDHHC7 (0.48) TET2TSHRHSD17B10MGAMGAA
SCHEMBL1413253 0.77 MGAM (0.44) TET2TSHRHSD17B10MGAMGAA
SCHEMBL3249891 0.77 TSHR (0.44) TET2TSHRHSD17B10MGAMGAA
SCHEMBL12820309 0.77 TSHR (0.42) TET2TSHRHSD17B10MGAMGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2480549-B1 Fused imidazo[3,2-d]pyrazines as PI3 kinase inhibitors FUNDACIÓN CT NAC DE INVESTIGACIONES ONCOLÓGICAS CARLOS III (ES) 2015-04-08 EP disclosed